Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Pfizer

You don't need to wait until you have huge sums saved to bulk up your passive income stream. Altria Group, the tobacco giant that markets Marlboro in the U.S., offers a 9.1% yield at recent prices.

2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever

Only a few investors have heard of Altria Group Inc. (NYSE: MO).

This Stock Has a Safe 9.1% Yield

Cigarette sales have been on the decline thanks to a combination of inflation and rising interest in wellness. Altria has expanded outside of traditional tobacco products through a series of acquisitions.

This Ultra-High-Yield Dividend Stock Is Trading at a Lower Price-to-Earnings Ratio Than the S&P 500

In trading on Friday, shares of Altria Group were yielding above the 9% mark based on its quarterly dividend (annualized to $3.92), with the stock changing hands as low as $42.90 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return.

Altria Group Crosses Above 9% Yield Territory

The cigarette maker's core business is crumbling. It might be too late to offset that decline with new products.

4 Reasons to Sell Altria Group Stock

Boston Properties

Kinder Morgan

Healthpeak Properties

AT&T

Verizon

Don't kick yourself if you didn't load up on investments returning 5% on your cash last year. They still can be found.

Juicy 5% Yields Are Now Rare — But They're Still Out There

Air Products and Chemicals

American States Water

Community Bank System

Cullen/Frost Bankers

C.H. Robinson Worldwide

Cincinnati Financial

Chevron

NextEra Energy

National Fuel Gas

Novartis

Old Republic International

PPG Industries

Combining quality factors with free cash flow yield, considered the best value metric of the last 33 years, can potentially deliver exceptional investing ideas. Here's how to find the highest FCF yielding dividend aristocrats, with strong balance sheets, good risk management, and strongly growing businesses. They yield an average yield of 9%, a peak yield of 9%, 10% consensus growth, a BBB+ credit rating, and 28% fundamentally justified upside potential in the next year.

13 Dividend Aristocrat Bargains Yielding As Much As 9%

The latest trading day saw Altria (MO) settling at $44.95, representing a +0.36% change from its previous close.

Altria (MO) Exceeds Market Returns: Some Facts to Consider

Anheuser-Busch InBev

Federal Realty Investment Trust

Leggett & Platt

Northwest Natural Gas

The Modern Investment App For a Richer Tomorrow (Sponsored) Robinhood set out to democratize investing to individuals, and it's not slowing down.

6 Highest Yielding Dividend Kings With Yields Up To 9.9%

Automatic Data Processing

Apollo Global Management

Brookfield Asset Management

Booking Hlds

British American Tobacco

CME Group

Electronic Arts

iShares Russell Top 200 Growth ETF

Mastercard

UnitedHealth Group

Visa

Joel Greenblatt's Magic formula is rules-based and focused on ROC - return on capital. The critical elements of Greenblatt's formula are quality, value, diversification, and annual rebalancing. The Zen Quality Portfolio utilizes these elements, combining ETFs and individual stocks, including those with very high ROC/PEG.

11 High-Quality Blue Chips Potentially Poised To Pop

Altria and Leggett & Platt are Dividend Kings currently yielding 8.8% and 9.8%, respectively. Both companies have seen revenue decline lately, and the bottom line isn't necessarily faring any better.

2 High-Yielding Stocks That Might Be Dividend Traps

Energy Transfer LP Unit

Vici Properties

Chasing yield when investing is a dangerous game. The highest-yielding stocks often have problems that cause their prices to fall and their yields to soar.

Create a Passive Income Stream: 3 Ultra-High Yield Stocks to Buy Now

Archer-Daniels-Midland Company

Procter & Gamble

In this article, I discuss three dividend stocks that offer little to no margin of safety from recent prices. Altria Group has struggled to turn around its core smoking market and faces challenges in growing newer businesses. There's a potential for a dividend cut. Archer-Daniels-Midland is an asset-heavy company with intense competition and no discernible competitive advantage. The recent rebound rally in price is unjustified.

Time To Sell: 3 Dividend Stocks With No Margin Of Safety

Brookfield Renewable Partners

Enbridge

Enterprise Products Partners

Altria stock has been soaring lately due to positive catalysts such as solid Q4 results and a major share buyback plan. That being said, there are a few major reasons why we remain unimpressed by the MO investment thesis. We share three high-yielding stocks with much better prospects than MO stock right now.

6-9% Yielding Dividend Growers: 1 To Avoid And 3 To Buy

Plains All American Pipeline

Rio Tinto plc Sponsored

Robinhood set out to democratize investing to individuals, and it's not slowing down.

5 Large Cap Blue Chip Bargains That Pay At Least 7% Dividends

Altria Group is monetizing its stake in Anheuser-Busch InBev to fund share repurchases, creating shareholder value. MO's decision to sell BUD shares makes sense due to BUD's unconvincing growth, high valuation, and low dividend. By selling BUD shares and buying back its own shares, Altria can increase earnings per share and make its dividend more sustainable.

Altria: 9% Yield And Huge Value Creation

Altria has begun selling its stake in Anheuser-Busch InBev. The company is dedicating the proceeds to buying back stock, in turn supporting the dividend as well.

Altria Is Cashing in Part of Its $12.7 Billion Chip: Here's Why That Makes the Stock a Buy

Dividend stocks are looking more and more attractive these days. Especially when you consider a given share of some companies can be prohibitively expensive.

3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50

Altria Group reached accelerated agreements to buy back $2.4 billion in common stock after selling part of its stake in Anheuser-Busch InBev.

Altria Buys Back Shares for $2.4 Billion

Golub Capital BDC

Innovative Industrial Properties

NewLake Capital Partners, Inc.

Universal Health Realty Income Trust

Universal Corp

The stock market is a dynamic place to invest, and selecting the correct equities to add to a portfolio may be likened to unearthing treasures within an enormous mine. When pursuing financial expansion, dividend stocks stand out as stability and income production pillars.

7 Superstar Stocks to Supercharge Your Dividend Returns

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Accelerated--Altria Enters $2.4 Billion Accelerated Share Repurchase Transactions in Connection with Closing of Offering of Anheuser-Busch InBev Stock.

Altria Enters $2.4 Billion Accelerated Share Repurchase Transactions in Connection with Closing of Offering of Anheuser-Busch InBev Stock

Flex Lng Ltd

There are multiple reasons dividend stocks are the first choice for many investors. First, these stocks provide regular cash flows that serve as a passive income source.

3 Undervalued Dividend Stocks Yielding Over 8% for Income-Hungry Investors

Altria (MO) benefits from its pricing power and focus on smoke-free products amid soft cigarette volumes.

Altria (MO) Gains on Pricing Power & Smoke-Free Strength

Johnson & Johnson

With a possible economic slowdown on the horizon, investors would be wise to consider stable, yield-friendly value stocks.

Best Value Stocks to Buy

News for Altria Stock (MO)